Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocare: IV Lidocaine for Rib Fracture Pain
NCT03571919Phase 4Withdrawn
- Sponsor
- Stanford University
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in pain (2 arms), sponsored by Stanford University. Primary endpoint: Opioid pain medicine usage at 24 hours. Planned start Jun 2018; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03571919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03571919.